<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9178107" created="29/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9178107</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="reactive_oxygen_specie" sem="Organic_compound_other">Reactive oxygen species</term> and <term id="T2" lex="antioxidant" sem="Organic_compound_other">antioxidants</term> in <term id="T3" lex="inflammatory_disease" sem="Other">inflammatory diseases</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">This paper aims to review the role of <term id="A1" sem="Inorganic_compound">free radical</term>-induced <term id="A2" sem="Other">tissue damage</term> and <term id="A3" sem="Other">antioxidant defence mechanisms</term> in <term id="T4" lex="inflammatory_disease" sem="Other">inflammatory diseases</term> that involve <term id="T5" lex="pathogenic_process" sem="Other">pathogenic processes</term> similar to the <term id="T6" lex="periodontal_disease" sem="Other">periodontal diseases</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="A1"/>
<clue>This paper aims to review the role of free radical-<clueType>induced</clueType> tissue damage and antioxidant defence mechanisms in inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="E1"/>
<clue>This paper aims <clueKT>to review</clueKT> the <clueType>role</clueType> <linkCause>of</linkCause> free radical-induced tissue damage and antioxidant defence mechanisms <linkTheme>in</linkTheme> inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="A3"/>
<clue>This paper aims <clueKT>to review</clueKT> the <clueType>role</clueType> <linkCause>of</linkCause> free radical-induced tissue damage and antioxidant defence mechanisms <linkTheme>in</linkTheme> inflammatory diseases that involve pathogenic processes similar to the periodontal diseases.</clue>
</event>
<sentence id="S3">There is a clearly defined and substantial role for <term id="T7" lex="free_radical" sem="Organic_compound_other">free radicals</term> or <term id="T8" lex="reactive_oxygen_specie" sem="Organic_compound_other">reactive oxygen species</term> (<term id="T9" lex="ROS" sem="Organic_compound_other">ROS</term>) in <term id="T10" lex="periodontitis" sem="Tissue_natural">periodontitis</term>, but little research has been performed in this area.</sentence>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="T7"/>
<clue>There is a clearly defined and substantial <clueType>role</clueType> <linkCause>for</linkCause> free radicals or reactive oxygen species (ROS) <linkTheme>in</linkTheme> periodontitis, but little research has been performed in this area.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="T9"/>
<clue>There is a clearly defined and substantial <clueType>role</clueType> <linkCause>for</linkCause> free radicals or reactive oxygen species (ROS) <linkTheme>in</linkTheme> periodontitis, but little research has been performed in this area.</clue>
</event>
<sentence id="S4">This paper reviews the considerable data available relating <term id="T11" lex="ROS" sem="Organic_compound_other">ROS</term> activity and antioxidant defence to <term id="T12" lex="inflammatory_disease" sem="Other">inflammatory diseases</term> and attempts to draw parallels with <term id="T13" lex="periodontitis" sem="Tissue_natural">periodontitis</term>, in an effort to stimulate more periodontal research in this important area.</sentence>
<sentence id="S5">The recent discovery of the <term id="T14" lex="transcription_factor_nuclear_factor_kappa_B" sem="Protein_complex">transcription factor nuclear factor kappa B</term> (<term id="T15" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>) is reviewed and several potential pathways for <term id="T17" lex="cytokine" sem="Protein_family_or_group">cytokine</term>-induced periodontal <term id="A4" sem="Other">tissue damage</term>, mediated by <term id="T18" lex="NF-kappa_B1" sem="Protein_molecule">NF-kappa B1</term> are discussed.</sentence>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T17"/>
<clue>The recent discovery of the transcription factor nuclear factor kappa B (NF-kappa B) is reviewed and several potential pathways for cytokine-<clueType>induced</clueType> <clueLoc>periodontal</clueLoc> tissue damage, mediated by NF-kappa B1 are discussed.</clue>
</event>
<event KT="Analysis" id="E7">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T18"/>
<clue>The recent discovery of the transcription factor nuclear factor kappa B (NF-kappa B) is reviewed and several potential pathways for cytokine-induced periodontal tissue damage, <clueType>mediated</clueType> <linkCause>by</linkCause> NF-kappa B1 are <clueKT>discussed</clueKT>.</clue>
</event>
<sentence id="S6">Emphasis is placed on <term id="T19" lex="cytokine" sem="Protein_family_or_group">cytokines</term> that have been studied in <term id="T20" lex="periodontitis" sem="Tissue_natural">periodontitis</term>, principally <term id="T21" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>, <term id="T22" lex="IL-1" sem="Protein_molecule">IL-1</term>, <term id="T23" lex="IL-6" sem="Protein_molecule">IL-6</term>, <term id="T24" lex="IL-8" sem="Protein_molecule">IL-8</term> and <term id="T25" lex="beta-interferon" sem="Protein_molecule">beta-interferon</term>.</sentence>
<sentence id="S7">The link between cellular production of such important mediators of <term id="T26" lex="inflammation" sem="Other">inflammation</term> and the <term id="T27" lex="antioxidant_(AO)_thiol" sem="Organic_compound_other">antioxidant (AO) thiols</term>, <term id="T28" lex="cysteine" sem="Amino_acid_monomer">cysteine</term> and <term id="T29" lex="reduced_glutathione" sem="Peptide">reduced glutathione</term> (<term id="T30" lex="GSH" sem="Peptide">GSH</term>), is discussed and it is hypothesised that <term id="T31" lex="NF-kappa_B_antagonist" sem="Organic_compound_other"><term id="T32" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> antagonists</term> may offer important <term id="T33" lex="therapeutic_benefit" sem="Other">therapeutic benefits</term>.</sentence>
<event KT="Other" id="E8">
<type class="Gene_expression"/>
<theme idref="T21"/>
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T22"/>
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T23"/>
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T24"/>
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Other" id="E12">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue>The link between <clueLoc>cellular</clueLoc> <clueType>production</clueType> <linkTheme>of</linkTheme> <corefTheme>such important mediators of inflammation</corefTheme> and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is discussed and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E13">
<type class="Correlation"/>
<theme idref="E8"/>
<theme idref="T27"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E14">
<type class="Correlation"/>
<theme idref="E8"/>
<theme idref="T28"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Correlation"/>
<theme idref="E8"/>
<theme idref="T29"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E27">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="T27"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E16">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="T28"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E17">
<type class="Correlation"/>
<theme idref="E9"/>
<theme idref="T29"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E18">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="T27"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="T28"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E20">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="T29"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T27"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T28"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Correlation"/>
<theme idref="E11"/>
<theme idref="T29"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E24">
<type class="Correlation"/>
<theme idref="E12"/>
<theme idref="T27"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E25">
<type class="Correlation"/>
<theme idref="E12"/>
<theme idref="T28"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
<event KT="Analysis" id="E26">
<type class="Correlation"/>
<theme idref="E12"/>
<theme idref="T29"/>
<clue>The <clueType>link</clueType> <linkTheme>between</linkTheme> cellular production of such important mediators of inflammation and the antioxidant (AO) thiols, cysteine and reduced glutathione (GSH), is <clueKT>discussed</clueKT> and it is hypothesised that NF-kappa B antagonists may offer important therapeutic benefits.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
